IP Library Granted Patent US 9,017,984
Granted Patent B2
US 9,017,984 · App. 13/529,990 · Granted Apr 28, 2015

Enhanced production of fatty acid derivatives

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,017,984
App. No.
13/529,990
Granted
Apr 28, 2015
Kind
B2
Abstract

Genetically engineered microorganisms that produce fatty alcohols from a sugar source by way of the fatty acid biosynthetic pathway, as well as methods of their use are provided.

Claims (22)

1. A recombinant microbial cell that is modified to express at least one exogenous nucleic acid sequence encoding a fatty acid derivative enzyme comprising an acyl-CoA reductase, wherein the recombinant microbial cell converts a carbohydrate carbon source into a fatty alcohol composition that is released into a fermentation media.

2. The recombinant microbial cell of claim 1 , wherein the microbial cell is a bacterial cell that is further modified to express an exogenous nucleic acid sequence encoding an acyl-CoA synthase (FadD).

3. The recombinant microbial cell of claim 1 , wherein the fatty alcohol composition that is released into the fermentation media is collected in an organic phase extracellularly.

4. The recombinant microbial cell of claim 1 , wherein the fatty alcohol composition is produced at a level of at least 1 mg/L.

5. The recombinant microbial cell of claim 1 , wherein a greater amount of fatty alcohol is produced at 37° C. than at 25° C.

6. The recombinant microbial cell of claim 1 , wherein the microbial cell is a bacterial cell, a yeast cell, an algal cell, or a filamentous fungal cell.

7. The recombinant microbial cell of claim 1 , wherein the fermentation media comprises one or more of C10, C12, C14, C16 and C18 fatty alcohols.

8. The genetically engineered recombinant microbial cell of claim 7 , wherein the fermentation media comprises C12 and C14 fatty alcohols.

9. The recombinant microbial cell of claim 1 , wherein the fermentation media comprises unsaturated fatty alcohols.

10. The recombinant microbial cell of claim 1 , wherein the fermentation media comprises saturated fatty alcohols.

11. The recombinant microbial cell of claim 1 , wherein the fermentation media comprises straight chain or branched chain fatty alcohols.

12. A recombinant microbial cell that is modified to express at least one exogenous nucleic acid sequence encoding a fatty acid derivative enzyme comprising an acyl-CoA reductase, wherein the recombinant microbial cell converts a fatty acid carbon source into a fatty alcohol composition that is released into a fermentation media.

13. The recombinant microbial cell of claim 12 , wherein an acyl-CoA synthase (fadD; EC 2.3.1.86, 6.2.1.3) is overexpressed.

14. The recombinant microbial cell of claim 12 , wherein an acyl-CoA dehydrogenase (fadE; EC 1.3.99.3, 1.3.99.-) is attenuated.

15. The recombinant microbial cell of claim 12 , wherein a fatty acid transport protein (fadL) is overexpressed.

16. The recombinant microbial cell of claim 12 , wherein said fatty acid carbon source is converted to acyl-CoA esters, which bind to transcription factor FadR.

17. The recombinant microbial cell of claim 12 , wherein a 3-ketoacyl-CoA thiolase (fadA; EC 2.3.1.16) is deleted or reduced.

18. The recombinant microbial cell of claim 12 , wherein a β-oxidation protein (fadB; EC 4.2.1.17, 5.1.2.3, 5.3.3.8, 1.1.1.35) is deleted or reduced.

19. The recombinant microbial cell of claim 12 , wherein an acyl-CoA dehydrogenase (YdiO; EC 1.3.99.-) is deleted or reduced.

20. The recombinant microbial cell of claim 12 , wherein a beta-ketoacyl-CoA thiolase (fadl; EC 2.3.1.16) is deleted or reduced.

21. The recombinant microbial cell of claim 12 , wherein an epimerase (fadJ; EC 5.1.2.3, 4.2.1.17, 1.1.1.35) is deleted or reduced.

22. The recombinant microbial cell of claim 12 , wherein said fatty acid carbon source is converted to acyl-CoA esters, which bind to transcription factor FadR.

Assignments (4)
SECURITY INTEREST Recorded Jun 2, 2025
From: GENOMATICA, INC.
To: OXFORD FINANCE LLC
Reel/Frame 071471/0770 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 9, 2019
From: REG LIFE SCIENCES, LLC
To: GENOMATICA, INC.
Reel/Frame 050695/0661 →
CORRECTIVE ASSIGNMENT TO CORRECT THE SCHEDULE A, LINE 221 PREVIOUSLY RECORDED ON REEL 034193 FRAME 0175. ASSIGNOR(S) HEREBY CONFIRMS THE CORRECT APPLICATION NUMBER. Recorded Apr 7, 2015
From: LS9, INC.
To: REG LIFE SCIENCES, LLC
Reel/Frame 035391/0384 →
AMENDMENT TO PATENT ASSIGNMENT Recorded Nov 7, 2014
From: LS9, INC.
To: REG LIFE SCIENCES, LLC
Reel/Frame 034193/0175 →